制药：从标准型到专业型胶囊规格，明胶空心胶囊、HPMC、吸入型和阴道型规格，专为满足各种治疗需求而设计。
营养保健品：面向消费者的营养保健品规格。为追求差异化的膳食补充剂生产商量身定制的胶囊和品牌原料。
Filter by:
Content Type
Oral delivery of glucagon-like peptide-1 (GLP-1) peptides has the potential to improve patient convenience and adherence, but gastrointestinal degradation and…
Targeting the distal small intestine, specifically the terminal ileum, remains one of the greatest challenges in oral drug delivery.
Innovation in oral formulation technologies has opened new avenues for the lifecycle management and patent protection of biologics. Technologies such as SNAC, LBFs,…
The success and adoption of oral GLP-1 RAs mark a shift in biologic drug delivery. Technologies such as permeation enhancers, LBFs, and enteric protection have made…
Healthcare systems are facing increasing pressure as record demand, an aging population, the burden of chronic disease, and economic inflation challenge clinics,…
Meeting consumers’ needs is the first priority for any successful business. For over-the-counter (OTC) medications and supplements, oral dosage forms have long been…
Advancing acid labile or sensitive APIs is often slowed by coating steps that add time and complexity. This webinar offers a concise, science led look at recent data…
Discover how next-generation capsule technologies, including Capsugel(R) Enprotect(R) capsules, are advancing targeted oral drug delivery, improving bioavailability,…
The capsule market is shifting due to the growing importance of ethics and sustainability in driving consumer behavior. The ethical spending market has shown…
Maximizing Productivity in Vegan and Vegetarian Capsules Filling
实现具有口服生物利用度的生物制剂递送，需要多个领域的专业知识。Lonza Capsugel 的科学家和技术专家携手合作致力于与……
生物疗法改变了慢性和复杂疾病的治疗，但它们的影响往往受到肠外给药需求的限制……
可持续发展是我们业务战略和运营理念的核心。
在我们最新的播客中，Lonza Capsugel 的 Frank Romanski 探讨了患者偏好如何重塑开发策略。
多年来，生物制剂的口服给药一直被认为不切实际。但是如果问题不在于给药途径本身，而在于我们采用的方法是否得当？
